It's a comprehensive approach that maximizes benefits while maintaining excellent tolerability
"CVS Caremark faces class action after removing Zepbound from formularies." fiercehealthcare.com CVS Caremark
Every December, the same story plays out
GLP-1 receptor agonist medications are under investigation and active litigation for alleged links to serious gastrointestinal and vision-related injuries, including gastroparesis, bowel obstruction, gallbladder disease, cyclic vomiting syndrome, ileus, and non-arteritic anterior ischemic optic neuropathy (NAION)
It may even reduce the risk of complications associated with diabetes, such as heart attack and stroke
Some patients benefit from stacking strategies: using compounded therapy while appealing insurance denials for branded drugs, or vice versa